In addition, the m6A-related proteins FTO, YTHDC1 and METTL3 are differentially expressed in GBM patients with mutant IDH and wild-type IDH. Differential expression of m6A regulators is closely associated with the expression of oncogenes in GBM (14). The gene discussed is METTL3; the disease is glioblastoma.